1 active not recruiting, 1 not yet recruiting, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Active not recruiting 1, Not yet recruiting 1 |
Follow Blinatumomab Injection: new trials by email Literature Review of Blinatumomab Injection trials Research Report on Blinatumomab Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia Blinatumomab Injection - B-cell Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukemia, Adult | Phase 1 / Phase 2 | Not yet recruiting | Memorial Sloan Kettering Cancer Center | 26 | 2026-09-01 | 2026-08-11 |
| Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL Blinatumomab Injection, Donor Lymphocyte Infusion (DLI) - ALL (Acute B-Lymphoblastic Leukemia) | Phase 1 | Recruiting | Liping Dou | 60 | 2024-12-01 | 2026-07-01 |
| Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia Blinatumomab Injection - Acute Lymphoblastic Leukemia, Adult B-Cell | Phase 2 | Active not recruiting | Assistance Publique - Hôpitaux de Paris | 95 | 2018-10-20 | 2021-05-03 |
Burkitt Lymphoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Assistance Publique - Hôpitaux de Paris (1) · Liping Dou (1) · Memorial Sloan Kettering Cancer Center (1)
China (1) · France (1) · United States (1)
Jae Park, MD (1)